These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


134 related items for PubMed ID: 2997102

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The identification of the aminoglycoside-phosphorylating enzymes APH(2'') and APH(3') from the characterization of their reaction products by high performance liquid chromatography.
    Lovering AM, White LO, Reeves DS.
    J Antimicrob Chemother; 1986 Feb; 17(2):147-54. PubMed ID: 3009381
    [Abstract] [Full Text] [Related]

  • 5. Failure of the disk diffusion test to detect tobramycin resistance in kanamycin-resistant Escherichia coli strains.
    Santanam P.
    J Clin Microbiol; 1984 Aug; 20(2):295-7. PubMed ID: 6092419
    [Abstract] [Full Text] [Related]

  • 6. Biochemical mechanism of resistance to aminoglycosidic antibiotics.
    Umezawa H.
    Adv Carbohydr Chem Biochem; 1974 Aug; 30():183-225. PubMed ID: 4143428
    [No Abstract] [Full Text] [Related]

  • 7. Overproduction of 3'-aminoglycoside phosphotransferase type I confers resistance to tobramycin in Escherichia coli.
    Menard R, Molinas C, Arthur M, Duval J, Courvalin P, Leclercq R.
    Antimicrob Agents Chemother; 1993 Jan; 37(1):78-83. PubMed ID: 8381641
    [Abstract] [Full Text] [Related]

  • 8. Amikacin resistance associated with a plasmid-borne aminoglycoside phosphotransferase in Escherichia coli.
    Perlin MH, Lerner SA.
    Antimicrob Agents Chemother; 1979 Nov; 16(5):598-604. PubMed ID: 393165
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain.
    Fernández-Martínez M, Miró E, Ortega A, Bou G, González-López JJ, Oliver A, Pascual A, Cercenado E, Oteo J, Martínez-Martínez L, Navarro F, Spanish Network for the Research in Infectious Diseases (REIPI).
    Int J Antimicrob Agents; 2015 Aug; 46(2):157-63. PubMed ID: 26022930
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Aminoglycoside antibodies: mechanism of action and resistance].
    Tanaka N.
    Nihon Saikingaku Zasshi; 1986 May; 41(3):587-601. PubMed ID: 3528555
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Drug-inactivating enzymes of bacteria grown in subminimal inhibitory concentrations of antibiotics.
    Grassi GG.
    Rev Infect Dis; 1979 May; 1(5):852-7. PubMed ID: 232298
    [Abstract] [Full Text] [Related]

  • 20. Occurrence of aminoglycoside-modifying enzymes in resistant strains of enterobacteria and Pseudomonas aeruginosa from several countries.
    Kettner M, Navarová J, Rýdl Z, Knothe H, Lebek G, Krcméry V.
    J Antimicrob Chemother; 1981 Sep; 8(3):175-85. PubMed ID: 6270050
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.